T1 and T2 Mapping for Characterization of Mediastinal Masses: A Feasibility study
Canadian Association of Radiologists Journal · 2023
DOI: 10.1177/08465371231160052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Association of Radiologists Journal, 2023. Verfasst von Kyongmin S Beck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Catholic University of Korea, Banpo-daero, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Thymoma, Mediastinal Cyst, Thymus Neoplasms, Lymphoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the feasibility and usefulness of T1 and T2 mapping in characterization of mediastinal masses.
Methods
From August 2019 through December 2021, 47 patients underwent 3.0-T chest MRI with T1 and post-contrast T1 mapping using modified look-locker inversion recovery sequences and T2 mapping using a T2-prepared single-shot shot steady-state free precession technique. Mean native T1, native T2, and post-contrast T1 values were measured by drawing the region of interest in the mediastinal masses, and enhancement index (EI) was calculated using these values.
Results
All mapping images were acquired successfully, without significant artifact. There were 25 thymic epithelial tumors (TETs), 3 schwannomas, 6 lymphomas, and 9 thymic cysts, and 4 other cystic tumors. TET, schwannoma, and lymphoma were grouped together as “solid tumor,” to be compared with thymic cysts and other tumors (“cystic tumors”). The mean post-contrast T1 mapping ( P < .001), native T2 mapping ( P < .001), and EI ( P < .001) values showed significant difference between these two groups. Among TETs, high risk TETs (thymoma types B2, B3, and thymic carcinoma) showed significantly higher native T2 mapping values (P = .002) than low risk TETs (thymoma types A, B1, and AB). For all measured variables, interrater reliability was good to excellent (intraclass coefficient [ICC]: .869∼.990) and intrarater reliability was excellent (ICC: .911∼.995).
Conclusion
The use of T1 and T2 mapping in MRI of mediastinal masses is feasible and may provide additional information in the evaluation of mediastinal masses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Catholic University of Korea, Banpo-daero, Seoul, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Catholic University of Korea, Banpo-daero, Seoul, Republic of Korea.
- Department of Hospital Pathology, Catholic University of Korea, Seoul, Republic of Korea.
- Department of Pathology, Konkuk University Chungju Hospital, Konkuk University School of Medicine, Chungju, Republic of Korea.
ORCID-Profile: Kyongmin S Beck, Suyon Chang
Zitieren
APA
Beck, K. S., Chang, S., Hyun, K., Sung, Y. E., Lee, K. Y., & Jung, J. I. (2023). T1 and T2 Mapping for Characterization of Mediastinal Masses: A Feasibility study. Canadian Association of Radiologists Journal. https://doi.org/10.1177/08465371231160052
Vancouver
Beck KS, Chang S, Hyun K, Sung YE, Lee KY, Jung JI. T1 and T2 Mapping for Characterization of Mediastinal Masses: A Feasibility study. Canadian Association of Radiologists Journal. 2023. doi:10.1177/08465371231160052
BibTeX
@article{Beck2023,
author = {Beck, Kyongmin S and Chang, Suyon and Hyun, Kwanyong and Sung, Yeoun Eun and Lee, Kyo-Young and Jung, Jung Im},
title = {T1 and T2 Mapping for Characterization of Mediastinal Masses: A Feasibility study},
journal = {Canadian Association of Radiologists Journal},
year = {2023},
doi = {10.1177/08465371231160052}
}
EUVIMED